Increased C-X-C Motif Chemokine Ligand 12 Levels in Cerebrospinal Fluid as a Candidate Biomarker in Sporadic Amyotrophic Lateral Sclerosis

Sporadic amyotrophic lateral sclerosis (sALS) is a fatal progressive neurodegenerative disease affecting upper and lower motor neurons. Biomarkers are useful to facilitate the diagnosis and/or prognosis of patients and to reveal possible mechanistic clues about the disease. This study aimed to identify and validate selected putative biomarkers in the cerebrospinal fluid (CSF) of sALS patients at early disease stages compared with age-matched controls and with other neurodegenerative diseases including Alzheimer disease (AD), spinal muscular atrophy type III (SMA), frontotemporal dementia behavioral variant (FTD), and multiple sclerosis (MS). SWATH acquisition on liquid chromatography-tandem mass spectrometry (LC–MS/MS) for protein quantitation, and ELISA for validation, were used in CSF samples of sALS cases at early stages of the disease. Analysis of mRNA and protein expression was carried out in the anterior horn of the lumbar spinal cord in post-mortem tissue of sALS cases (terminal stage) and controls using RTq-PCR, and Western blotting, and immunohistochemistry, respectively. SWATH acquisition on liquid chromatography-tandem mass spectrometry (LC–MS/MS) revealed 51 differentially expressed proteins in the CSF in sALS. Receiver operating characteristic (ROC) curves showed CXCL12 to be the most valuable candidate biomarker. We validated the values of CXCL12 in CSF with ELISA in two different cohorts. Besides sALS, increased CXCL12 levels were found in MS but were not altered in AD, SMA, and FTD. Therefore, increased CXCL12 levels in the CSF can be useful in the diagnoses of MS and sALS in the context of the clinical settings. CXCL12 immunoreactivity was localized in motor neurons in control and sALS, and in a few glial cells in sALS at the terminal stage; CXCR4 was in a subset of oligodendroglial-like cells and axonal ballooning of motor neurons in sALS; and CXCR7 in motor neurons in control and sALS, and reactive astrocytes in the pyramidal tracts in terminal sALS. CXCL12/CXCR4/CXCR7 axis in the spinal cord probably plays a complex role in inflammation, oligodendroglial and astrocyte signaling, and neuronal and axonal preservation in sALS.

[1]  L. Albini-Riccioli,et al.  Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis , 2020, Journal of Neurology.

[2]  K. Mortezaee,et al.  Intranasal delivery of SDF‐1α‐preconditioned bone marrow mesenchymal cells improves remyelination in the cuprizone‐induced mouse model of multiple sclerosis , 2020, Cell biology international.

[3]  M. Calabrese,et al.  Increase of CSF inflammatory profile in a case of highly active multiple sclerosis , 2019, BMC Neurology.

[4]  P. van Damme,et al.  Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis? , 2019, Journal of Neurology, Neurosurgery, and Psychiatry.

[5]  I. Ferrer,et al.  Unveiling the olfactory proteostatic disarrangement in Parkinson's disease by proteome-wide profiling , 2019, Neurobiology of Aging.

[6]  J. Clarimón,et al.  CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrum , 2018, Neurology.

[7]  P. Nestor,et al.  Significance of CSF NfL and tau in ALS , 2018, Journal of Neurology.

[8]  F. Llorens,et al.  YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression , 2018, Aging.

[9]  R. Reynolds,et al.  Molecular pathology of Multiple Sclerosis lesions reveals a heterogeneous expression pattern of genes involved in oligodendrogliogenesis , 2018, Experimental Neurology.

[10]  Guo-Yuan Yang,et al.  cxcl12-engineered endothelial progenitor cells enhance neurogenesis and angiogenesis after ischemic brain injury in mice , 2018, Stem Cell Research & Therapy.

[11]  F. Facchiano,et al.  Inflammatory intrathecal profiles and cortical damage in multiple sclerosis , 2018, Annals of neurology.

[12]  K. Jin,et al.  SDF-1/CXCR7 Chemokine Signaling is Induced in the Peri-Infarct Regions in Patients with Ischemic Stroke , 2018, Aging and disease.

[13]  M. Turner,et al.  Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis , 2018, Annals of neurology.

[14]  R. Spataro,et al.  CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis , 2018, Journal of Neurology.

[15]  K. Wilson,et al.  Using newborn screening analytes to identify cases of neonatal sepsis , 2017, Scientific Reports.

[16]  I. Ferrer,et al.  YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias , 2017, Molecular Neurodegeneration.

[17]  I. Ferrer,et al.  Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer’s disease progression , 2017, Scientific Reports.

[18]  J. Ávila,et al.  Absence of CX3CR1 impairs the internalization of Tau by microglia , 2017, Molecular Neurodegeneration.

[19]  Zachary C Danziger,et al.  Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes , 2017, Disease Models & Mechanisms.

[20]  Y. Wang,et al.  CXCR7 Participates in CXCL12-mediated Cell Cycle and Proliferation Regulation in Mouse Neural Progenitor Cells , 2016, Current molecular medicine.

[21]  Marco Y. Hein,et al.  The Perseus computational platform for comprehensive analysis of (prote)omics data , 2016, Nature Methods.

[22]  B. Solomon,et al.  Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1G93A mice model of ALS , 2016, Journal of Neuroinflammation.

[23]  J. Qin,et al.  CXCL12/CXCR4 Axis Improves Migration of Neuroblasts Along Corpus Callosum by Stimulating MMP-2 Secretion After Traumatic Brain Injury in Rats , 2016, Neurochemical Research.

[24]  A. Ben-nun,et al.  Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like disease , 2016, Journal of Neuroinflammation.

[25]  Leon E. Toussaint,et al.  Non-alcoholic fatty liver disease induces signs of Alzheimer’s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model , 2016, Journal of Neuroinflammation.

[26]  Jialin C. Zheng,et al.  CXCR7 Mediates Neural Progenitor Cells Migration to CXCL12 Independent of CXCR4 , 2015, Stem cells.

[27]  P. Bossù,et al.  Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis , 2014, Journal of Neuroinflammation.

[28]  J. Browning,et al.  Feasibility of the Use of Combinatorial Chemokine Arrays to Study Blood and CSF in Multiple Sclerosis , 2013, PloS one.

[29]  A. Ardelt,et al.  Stromal derived growth factor-1 (CXCL12) modulates synaptic transmission to immature neurons during post-ischemic cerebral repair , 2013, Experimental Neurology.

[30]  R. Ransohoff,et al.  Chemokine CXCL12 in neurodegenerative diseases: an SOS signal for stem cell-based repair , 2012, Trends in Neurosciences.

[31]  Samira N. Kashefi,et al.  Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study , 2012, Acta Neuropathologica.

[32]  H. Müller,et al.  Chemokines in CNS injury and repair , 2012, Cell and Tissue Research.

[33]  Ludovic C. Gillet,et al.  Targeted Data Extraction of the MS/MS Spectra Generated by Data-independent Acquisition: A New Concept for Consistent and Accurate Proteome Analysis* , 2012, Molecular & Cellular Proteomics.

[34]  T. Hortobágyi,et al.  Amyotrophic Lateral Sclerosis, Primary Lateral Sclerosis and Spinal Muscular Atrophy , 2011 .

[35]  Nick C Fox,et al.  Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.

[36]  R. Klein,et al.  CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination , 2010, Proceedings of the National Academy of Sciences.

[37]  R. Strieter,et al.  Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis , 2010, Proceedings of the National Academy of Sciences.

[38]  J. Kira,et al.  CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis , 2010, Journal of Neuroimmunology.

[39]  S. Heinisch,et al.  SDF-1α/CXCL12 enhances GABA and glutamate synaptic activity at serotonin neurons in the rat dorsal raphe nucleus , 2010, Neuropharmacology.

[40]  R. Lefkowitz,et al.  β-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7 , 2009, Proceedings of the National Academy of Sciences.

[41]  F. Baleux,et al.  CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. , 2009, Blood.

[42]  L. Defebvre,et al.  CSF profiles of angiogenic and inflammatory factors depend on the respiratory status of ALS patients , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[43]  M. Swash,et al.  Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[44]  R. Ransohoff,et al.  Multiple roles of chemokine CXCL12 in the central nervous system: A migration from immunology to neurobiology , 2008, Progress in Neurobiology.

[45]  M. Mattson,et al.  Impaired SDF1/CXCR4 signaling in glial progenitors derived from SOD1G93A mice , 2007, Journal of neuroscience research.

[46]  K. Brown,et al.  Pulmonary Stromal-Derived Factor-1 Expression and Effect on Neutrophil Recruitment during Acute Lung Injury1 , 2007, The Journal of Immunology.

[47]  R. Klein,et al.  CXCL12 Limits Inflammation by Localizing Mononuclear Infiltrates to the Perivascular Space during Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.

[48]  J. Berman,et al.  A role for CXCL12 (SDF-1α) in the pathogenesis of multiple sclerosis: Regulation of CXCL12 expression in astrocytes by soluble myelin basic protein , 2006, Journal of Neuroimmunology.

[49]  P. Kitabgi,et al.  Complex effects of stromal cell‐derived factor‐1α on melanin‐concentrating hormone neuron excitability , 2005, The European journal of neuroscience.

[50]  A. Uccelli,et al.  Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[51]  R. Klein,et al.  Immune and nervous system CXCL12 and CXCR4: parallel roles in patterning and plasticity. , 2004, Trends in immunology.

[52]  R. Bonavia,et al.  Chemokines and their receptors in the CNS: expression of CXCL12/SDF-1 and CXCR4 and their role in astrocyte proliferation. , 2003, Toxicology letters.

[53]  H. Link,et al.  Secondary lymphoid organ chemokines are elevated in the cerebrospinal fluid during central nervous system inflammation , 2003, Journal of Neuroimmunology.

[54]  C. Culmsee,et al.  A Dual Role for the SDF-1/CXCR4 Chemokine Receptor System in Adult Brain: Isoform-Selective Regulation of SDF-1 Expression Modulates CXCR4-Dependent Neuronal Plasticity and Cerebral Leukocyte Recruitment after Focal Ischemia , 2002, The Journal of Neuroscience.

[55]  M. Swash,et al.  El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[56]  T. Honjo,et al.  Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. , 1993, Science.

[57]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[58]  J. Qin,et al.  CXCL12 promotes proliferation of radial glia like cells after traumatic brain injury in rats. , 2019, Cytokine.

[59]  M. Beckerman.  Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration , 2015 .

[60]  J. Newcombe,et al.  Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. , 2006, Brain : a journal of neurology.

[61]  W. Youden,et al.  Index for rating diagnostic tests , 1950, Cancer.